HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Xu Selected Research

albiflorin

1/2019Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome.
9/2012Screening for the efficacy on lipid accumulation in 3T3-L1 cells is an effective tool for the identification of new anti-diabetic compounds.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Xu Research Topics

Disease

284Neoplasms (Cancer)
06/2024 - 11/2004
73Inflammation (Inflammations)
04/2024 - 03/2002
64Infections
12/2023 - 08/2002
41Hepatocellular Carcinoma (Hepatoma)
01/2024 - 08/2002
41Neoplasm Metastasis (Metastasis)
01/2024 - 08/2002
41Fibrosis (Cirrhosis)
11/2023 - 08/2002
39Alzheimer Disease (Alzheimer's Disease)
01/2024 - 01/2009
36Lung Neoplasms (Lung Cancer)
06/2023 - 10/2004
28Wounds and Injuries (Trauma)
12/2023 - 01/2002
25Carcinogenesis
05/2024 - 04/2012
25Liver Cirrhosis (Hepatic Cirrhosis)
02/2024 - 02/2009
24Pain (Aches)
04/2024 - 08/2006
24Breast Neoplasms (Breast Cancer)
06/2023 - 03/2011
23Stomach Neoplasms (Stomach Cancer)
03/2024 - 03/2006
22Colorectal Neoplasms (Colorectal Cancer)
05/2024 - 08/2002
21Type 2 Diabetes Mellitus (MODY)
05/2024 - 01/2011
21Hypoxia (Hypoxemia)
12/2023 - 04/2010
19Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 05/2008
19Cognitive Dysfunction
03/2024 - 01/2015
19Osteoporosis
12/2023 - 12/2013
17Hemorrhage
05/2024 - 08/2007
17COVID-19
01/2024 - 01/2020
17Pancreatitis
10/2023 - 05/2003
16Leukemia
11/2023 - 04/2013
16Sepsis (Septicemia)
10/2023 - 11/2009
15Necrosis
05/2023 - 09/2004
14Melanoma (Melanoma, Malignant)
01/2024 - 01/2016
14Myocardial Infarction
10/2023 - 01/2012
14Pneumonia (Pneumonitis)
04/2023 - 08/2002
14Insulin Resistance
01/2023 - 04/2003
13Ischemia
02/2021 - 01/2003
13Carcinoma (Carcinomatosis)
02/2020 - 05/2002
12Non-alcoholic Fatty Liver Disease
01/2024 - 09/2014
12Hematologic Neoplasms (Hematological Malignancy)
07/2023 - 01/2015
12Prostatic Neoplasms (Prostate Cancer)
12/2022 - 12/2007
12Infarction (Infarctions)
04/2022 - 01/2012
11Dehydration (Water Stress)
04/2024 - 03/2012
11Body Weight (Weight, Body)
12/2023 - 04/2003
11Liver Neoplasms (Liver Cancer)
11/2023 - 08/2002
11Heart Arrest (Cardiac Arrest)
01/2023 - 03/2015
11Liver Diseases (Liver Disease)
01/2023 - 10/2008
11Obesity
01/2022 - 09/2011
10Acute Lung Injury
01/2024 - 09/2006
10Stroke (Strokes)
01/2024 - 04/2014
10Neuroinflammatory Diseases
11/2023 - 04/2013
10Virus Diseases (Viral Diseases)
12/2022 - 09/2005
10Cicatrix (Scar)
10/2022 - 09/2002
9Shock
04/2024 - 02/2009
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2024 - 08/2012
9Neurodegenerative Diseases (Neurodegenerative Disease)
07/2023 - 08/2015
9Diabetic Retinopathy (Retinopathy, Diabetic)
05/2023 - 01/2011
9Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 01/2009

Drug/Important Bio-Agent (IBA)

101Proteins (Proteins, Gene)FDA Link
05/2024 - 02/2004
51Biomarkers (Surrogate Marker)IBA
04/2024 - 12/2007
35Glucose (Dextrose)FDA LinkGeneric
04/2024 - 04/2003
32MicroRNAs (MicroRNA)IBA
06/2024 - 11/2008
32Therapeutic UsesIBA
04/2024 - 01/2002
30Messenger RNA (mRNA)IBA
02/2024 - 01/2003
26CytokinesIBA
10/2023 - 08/2002
23Small Interfering RNA (siRNA)IBA
01/2023 - 03/2004
19Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2024 - 11/2004
19Anti-Bacterial Agents (Antibiotics)IBA
02/2024 - 07/2013
19Long Noncoding RNAIBA
02/2024 - 05/2016
19RNA (Ribonucleic Acid)IBA
11/2023 - 05/2012
19LipidsIBA
01/2022 - 04/2006
18EnzymesIBA
04/2024 - 03/2005
18AntigensIBA
05/2023 - 02/2011
18DNA (Deoxyribonucleic Acid)IBA
07/2022 - 09/2006
15Insulin (Novolin)FDA Link
03/2023 - 01/2009
14Antiviral Agents (Antivirals)IBA
10/2023 - 06/2008
13Immune Checkpoint InhibitorsIBA
01/2024 - 01/2019
13Phosphotransferases (Kinase)IBA
09/2023 - 10/2012
13Oxygen (Dioxygen)IBA
01/2023 - 06/2005
13Chimeric Antigen ReceptorsIBA
11/2022 - 01/2015
12LigandsIBA
04/2024 - 11/2004
12CateninsIBA
01/2024 - 09/2013
11Interleukin-6 (Interleukin 6)IBA
04/2024 - 04/2005
11Eosine Yellowish-(YS) (Eosin)IBA
01/2024 - 07/2010
11VaccinesIBA
12/2023 - 06/2010
11Cisplatin (Platino)FDA LinkGeneric
11/2023 - 02/2005
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2023 - 01/2003
11Coal (Coals)IBA
12/2021 - 11/2013
10Hematoxylin (Haematoxylon)IBA
01/2024 - 07/2010
10InflammasomesIBA
01/2024 - 04/2013
10Circular RNAIBA
12/2023 - 01/2019
10Histones (Histone)IBA
06/2023 - 11/2009
10Bile Acids and Salts (Bile Acids)IBA
03/2023 - 09/2014
10CarcinogensIBA
01/2023 - 05/2015
10Indicators and Reagents (Reagents)IBA
01/2023 - 12/2005
10AntioxidantsIBA
01/2022 - 02/2015
9AntibodiesIBA
01/2024 - 07/2004
9LipopolysaccharidesIBA
01/2024 - 06/2008
9Triglycerides (Triacylglycerol)IBA
01/2023 - 01/2019

Therapy/Procedure

147Therapeutics
05/2024 - 05/2003
40Drug Therapy (Chemotherapy)
05/2024 - 02/2005
40Immunotherapy
03/2024 - 08/2011
17Cardiopulmonary Resuscitation (CPR)
01/2023 - 03/2015
16Transplantation
02/2024 - 02/2011
14Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2024 - 01/2010
13Radiotherapy
01/2023 - 05/2006